Disease Prevention

HHS advances plan to produce 4.8 million H5N1 vaccine doses Officials have identified a fill-and-finish opening on a production line at a vaccine company partner and said the activity won't disrupt the supply of seasonal flu vaccine. CIDRAP

...

Dawn O'Connell, JD, said health officials have identified a manufacturing line at one of its manufacturing partners for fill-and-finish steps, without disrupting production of seasonal flu vaccine. Currently, the vaccine is in bulk form and will be produced in multidose vials.

...

How a simulation is informing COVID-19 vaccine policy after our 'return to normal' As the saying goes "There is no such thing as normal" and this has been especially true after the pandemic. Medical Xpress

...

Now, there is a complex global situation where populations in different countries have unique hybrid immunity landscapes, born from a wide range of vaccination history and exposure history combinations.

In 2023, we needed to consider what hybrid immunity meant for booster vaccinations. And what different types of hybrid immunity meant for future vaccination strategies.